Blood Glucose Monitoring System Market to Grow at a CAGR of 6.3% over 2025 to 2032; Growing Patient Awareness to Accentuate Market Growth

The global blood glucose monitoring system market size was valued at USD 17.20 billion in 2024. The market is projected to grow from USD 18.03 billion in 2025 to USD 27.73 billion by 2032, exhibiting a CAGR of 6.3% during the forecast period.  Fortune Business Insights™ presents this information in its report titled “Blood Glucose Monitoring System Market Size, Share & Industry Analysis, By Device Type (Continuous Glucose Monitoring (CGM) Systems [Sensors and Transmitters & Receivers] and Self-Monitoring Blood Glucose (SMBG) Systems [Blood Glucose Meters, Test Strips, and Lancets]), By Type (Non-invasive and Invasive), By Modality (Wearable and Non-wearable), By Patient Type (Type 1 Diabetes and Type 2 Diabetes), By Distribution Channel (Retail Sales and Institutional Sales), and Regional Forecast, 2025-2032”.

Blood glucose monitoring system are vital for diabetes management, with surging demand due to global rise in diabetic cases. In 2024, approximately 589 million adults (aged between 20-79 years) were diagnosed with diabetes, as reported by International Diabetes Federation (IDF). Market growth is supported by innovations in monitoring technologies, expanding healthcare infrastructure, and increased patient awareness. 

Know Labs, Inc., Launched the KnowU to Strengthen its Product Portfolio in the Market

Know Labs, Inc., introduced KnowU in February 2024, a non-invasive, wearable continuous glucose monitor using radiofrequency and machine learning. Designed for comfort and convenience, the devices deliver continuous glucose reading via a mobile app, aiming for FDA clearance following clinical trials.    

Increasing Prevalence of Diabetes to Drive Market Growth

Global diabetes cases are rising sharply due to sedentary lifestyles and urbanization, boosting the need for continuous monitoring. Europe alone is expected to witness diabetic patients grow from 65.6 million (2024) to 72.4 million by 2050, as per IDF study. Over 9 million users rely on CGM devices for daily management, according to Mary Ann Liebert, Inc. article. Combined with new product launches and favorable reimbursement policies, this trend is propelling blood glucose monitoring system market growth.

However, insufficient reimbursement programs in the emerging countries are likely to hinder market expansion.

Industry Participants Focus on R&D Efforts to Gain Competitive Edge

Leading players such as F. Hoffmann-La Roche Ltd., Dexcom, Inc and Abbott held the prominent share in the global blood glucose monitoring system market due to their robust product range, extensive R&D, and strong global presence. Abbott launch of Lingo, a cover-the-counter CGM device, exemplifies this strategy. Moreover, emerging companies such as Afon Technology are driving innovation in non-invasive monitoring, signaling future disruption and diversification in the market. 

List of Key Players Mentioned in the Report

• Abbott (U.S.)
• Braun SE (Germany)
• Dexcom, Inc. (U.S.)
• Ascensia Diabetes Care Holdings AG (Switzerland)
• Medtronic (Ireland)
• Hoffmann-La Roche Ltd (Switzerland)
• Terumo Corporation (Japan)
• LifeScan IP Holdings, LLC (U.S.)
• Senseonics (U.S.)

To get a detailed report summary and research scope of this market, click here:

www.fortunebusinessinsights.com/blood-glucose-monitoring-market-100648

Key Industry Development

• June 2024- Abbott secured FDA approval for its over-the-counter CGM devices, Lingo and Libre Rio, reinforcing its consumer health offerings.

Further Report Findings

• North America captured the key blood glucose monitoring system market share, stood at USD 57 billion in 2024. Growth is driven by rising diabetes prevalence, strong awareness, and high uptake of advanced monitoring technologies. According to IDF (2025), diabetes cases in the region and the Caribbean are expected to rise from 56.2 million to 68.1 million by 2050. Favourable reimbursement and rising healthcare spending further support regional growth.
• Europe is poised to expand with a considerable CAGR during the study period due to the rising consciousness towards diabetes management, growing uptake of blood glucose monitoring systems in home care settings.  

Table of Segmentation